CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma

References

Page 1

	Year	Citations
Cancer statistics, 2012 Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal CA A Cancer Journal for Clinicians	2012	10.7K
Widespread microRNA repression by Myc contributes to tumorigenesis Tsung-Cheng Chang, Duonan Yu, Yun‐Sil Lee, Nature Genetics Widespread Microrna RepressionSmall RnaMicrorna DetectionMedicineCell Biology	2007	1.3K
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis Li Ma, Jennifer J. Young, Harsha Prabhala, Nature Cell Biology Tumor BiologyMedicineMyc/mycn-activated MicrornaSmall RnaMicrorna Detection	2010	1.3K
Modelling Myc inhibition as a cancer therapy Laura Soucek, Jonathan R. Whitfield, Carla P. Martins, Nature Myc InhibitionTumor BiologyOncologyOncogenic AgentMedicine	2008	805
Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research Consortium Shahrokh F. Shariat, Pierre I. Karakiewicz, Ganesh S. Palapattu, The Journal of Urology	2006	696
CIP2A Inhibits PP2A in Human Malignancies Melissa R. Junttila, Pietri Puustinen, Minna Niemelä, Cell Tumor BiologyCip2a Inhibits Pp2aMedicinePathologyCancer Biology	2007	675
Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation Tsung-Cheng Chang, Lauren R Zeitels, Hun‐Way Hwang, Proceedings of the National Academy of Sciences Molecular RegulationHigh Myc StateMyc Activity ResultsTumor BiologyTranscriptional Regulation	2009	421
The molecular role of Myc in growth and transformation: recent discoveries lead to new insights Linda M. Facchini, Linda Z. Penn The FASEB Journal Molecular RegulationMyc-max Transcriptional RegulationMyc ResearcherMolecular BiologyCytoskeleton	1998	381
HMGA2 and Smads Co-regulate SNAIL1 Expression during Induction of Epithelial-to-Mesenchymal Transition Sylvie Thuault, E‐Jean Tan, Héctor Peinado, Journal of Biological Chemistry	2008	371
Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the <i>telomerase reverse transcriptase</i> promoter during differentiation of HL60 cells Dawei Xu, Nikita Popov, Mi Hou, Proceedings of the National Academy of Sciences Epigenetic ChangeMolecular BiologyEpigeneticsTranscriptional RegulationCell Regulation	2001	322

Page 1